Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Primary dermal melanoma: a distinct subtype of melanoma.

Swetter SM, Ecker PM, Johnson DL, Harvell JD.

Arch Dermatol. 2004 Jan;140(1):99-103.

PMID:
14732666
2.

Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma.

Cassarino DS, Cabral ES, Kartha RV, Swetter SM.

Arch Dermatol. 2008 Jan;144(1):49-56. doi: 10.1001/archdermatol.2007.16.

PMID:
18209168
3.

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.

Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS.

Am J Surg Pathol. 2005 Mar;29(3):305-17.

PMID:
15725798
4.

Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classification.

Bowen GM, Chang AE, Lowe L, Hamilton T, Patel R, Johnson TM.

Arch Dermatol. 2000 Nov;136(11):1397-9.

PMID:
11074704
5.

Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.

McNutt NS, Urmacher C, Hakimian J, Hoss DM, Lugo J.

J Cutan Pathol. 1995 Dec;22(6):502-17.

PMID:
8835170
6.

Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.

de Almeida LS, Requena L, Rütten A, Kutzner H, Garbe C, Pestana D, Gomes MM.

Am J Dermatopathol. 2008 Jun;30(3):207-15. doi: 10.1097/DAD.0b013e3181716e6b.

PMID:
18496419
7.

Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting.

Tan KB, Moncrieff M, Thompson JF, McCarthy SW, Shaw HM, Quinn MJ, Li LX, Crotty KA, Stretch JR, Scolyer RA.

Am J Surg Pathol. 2007 Dec;31(12):1902-12.

PMID:
18043047
8.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

PMID:
16595783
9.

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Ann Surg Oncol. 2006 Dec;13(12):1655-63. Epub 2006 Oct 3.

PMID:
17016755
10.

Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.

Hitchcock MG, McCalmont TH, White WL.

Am J Surg Pathol. 1999 Dec;23(12):1506-13.

PMID:
10584704
11.

Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature.

Zembowicz A, McCusker M, Chiarelli C, Dei Tos AP, Granter SR, Calonje E, McKee PH.

Am J Dermatopathol. 2001 Jun;23(3):167-75. Review.

PMID:
11391094
12.

Sentinel node in melanoma patients: triple negativity with routine techniques and PCR as positive prognostic factor for survival.

Denninghoff VC, Falco J, Kahn AG, Trouchot V, Curutchet HP, Elsner B.

Mod Pathol. 2008 Apr;21(4):438-44. doi: 10.1038/modpathol.3801020. Epub 2008 Jan 25.

13.

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.

Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.

Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22.

PMID:
19553103
14.

Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.

Petitt M, Allison A, Shimoni T, Uchida T, Raimer S, Kelly B.

J Am Acad Dermatol. 2009 Nov;61(5):819-28. doi: 10.1016/j.jaad.2009.04.026.

PMID:
19836642
15.

Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.

Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.

Br J Dermatol. 2007 Jul;157(1):58-67. Epub 2007 May 14.

PMID:
17501957
16.

Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.

Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, Guerry D.

J Clin Oncol. 2005 Nov 1;23(31):8048-56.

PMID:
16258103
17.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.

Arch Dermatol. 2009 Oct;145(10):1105-13. doi: 10.1001/archdermatol.2009.209.

PMID:
19841396
18.

[Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].

Keijzer R, Bril H, van der Loo EM, de Graaf PW.

Ned Tijdschr Geneeskd. 2004 May 1;148(18):884-8. Dutch.

PMID:
15152391
19.

Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node.

Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL.

Mod Pathol. 2004 Jul;17(7):747-55.

20.

Malignant melanoma within an intradermal nevus.

Tajima Y, Nakajima T, Sugano I, Nagao K, Kondo Y.

Am J Dermatopathol. 1994 Jun;16(3):301-6.

PMID:
7943639

Supplemental Content

Support Center